Rocco Caliandro

Rocco Caliandro

Auto-generated profile, based on publicly available information

Rocco Caliandro

Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2026 in Circulation Research
Verified
Journal Article
Closed access
RCRocco Caliandro
Rocco Caliandro
MLMerel L. Ligtermoet
Merel L. Ligtermoet
AGAlexandra E. Giovou
Alexandra E. Giovou
AHAzra Husetić
Azra Husetić
ABArie R. Boender
Arie R. Boender
MGMonika Gladka
Monika Gladka
BACKGROUND: Long noncoding RNAs (lncRNA) have emerged as critical regulators in cardiovascular biology, influencing cardiac development, remodeling, and regeneration. Zeb2os (zeb2 opposite strand), a natural antisense transcript of the Zeb2 (zinc finger E-box-binding homeobox 2) gene, has been linked to these processes in various organs. Although ZEB2 promotes cardiac repair, the role of Zeb2os in these processes remains unclear. This study investigates the role of Zeb2os in modulating ZEB2 expression and cardiac remodeling after ischemic injury. METHODS: We used adeno-associated virus vectors to overexpress Zeb2os in mouse models of cardiac IR (ischemia/reperfusion) injury. RNA sequencing, immunofluorescence, and high-resolution respirometry were used to evaluate the effects of Zeb2os delivery on gene expression, ZEB2 reactivation, cardiomyocyte phenotype, scar composition, and mitochondrial function. Experiments in cultured cardiomyocytes under hypoxia further explored the regulatory dynamics between Zeb2os and Zeb2 . RESULTS: We identified Zeb2os as a hypoxia-responsive lncRNA that displays an inverse and oscillatory expression pattern with Zeb2 in both in vitro and in vivo models of cardiac injury. Functional experiments revealed that Zeb2os negatively regulates ZEB2 expression, impairing the cardiomyocyte dedifferentiation and metabolic remodeling necessary for effective repair. Adeno-associated virus-mediated delivery of Zeb2os resulted in preserved sarcomere structure, altered scar composition, reduced expression of regenerative genes, and diminished cardiac function following injury. In contrast, silencing of Zeb2os increased ZEB2 protein expression, suggesting a potential therapeutic strategy to enhance repair. Mechanistically, modulation of Zeb2os levels inversely regulated ZEB2 protein expression, whereas ZEB2 modulation did not affect Zeb2os levels, indicating a unidirectional regulatory axis between the 2 transcripts. CONCLUSIONS: Our findings identify Zeb2os as a stress-responsive inhibitor of ZEB2 reactivation that limits cardiomyocyte plasticity and hinders repair following ischemic injury. Given its specific activity under ischemic conditions, targeting Zeb2os may represent a novel therapeutic strategy to enhance endogenous cardiac regeneration.

31 October 2025 in PNAS Nexus
Verified
Journal Article
Open access
LBLaurens W. J. Bosman
Laurens W. J. Bosman
HAHamid el Azzouzi
Hamid el Azzouzi
LKLieke Kros
Lieke Kros
YRYanto Ridwan
Yanto Ridwan
NVNicole van Vliet
Nicole van Vliet
CZChris Innocentius De Zeeuw
Chris Innocentius De Zeeuw
Williams syndrome is a developmental disorder caused by a microdeletion entailing the loss of a single copy of 25–27 genes on chromosome 7q11.23. Patients suffer from cardiovascular and neuropsychological symptoms. Structural abnormalities of the cardiovascular system in Williams syndrome have been attributed to the hemizygous loss of the elastin (ELN) gene. In contrast, the neuropsychological consequences of Williams syndrome, including sensorimotor deficits, hypersociability, and cognitive impairments, have been mainly attributed to altered expression of transcription factors, like LIMK1, GTF2I, and GTF2IRD1, while the potential impact of altered cerebrovascular function has been largely overlooked. To study the relationship between Williams syndrome mutations and vascularization of both the heart and brain, we generated a mouse model carrying a relatively long microdeletion Del(5Ncf1-Fkbp6). Heterozygous Del(5Ncf1-Fkbp6) mice had elongated and tortuous aortas but, unlike Eln haploinsufficient mice, showed no signs of structural cardiac hypertrophy. Remarkably, we also observed structural abnormalities in coronary and brain vessels, including disorganized extracellular matrices. Importantly, the mutant mice faithfully replicated both cardiovascular and neuropsychological symptoms observed in patients. The phenotype was even more comprehensive than in former models, with structure–function correlations evident in aberrant auditory and motor behaviors resembling those in patients with Williams syndrome. Together, our findings suggest that not only cardiovascular but also neuropsychological symptoms in Williams syndrome may be driven in part by vascular abnormalities affecting both heart and brain.

13 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LHLiangyu Hu
Liangyu Hu
ARAlexia Helena van Rinsum
Alexia Helena van Rinsum
RCRocco Caliandro
Rocco Caliandro
XQXi Qi
Xi Qi
SFShuxiu Fan
Shuxiu Fan
DZDeli Zhang
Deli Zhang
Cardiovascular diseases are often associated with impairment in mitochondrial function detected by reduced mitochondrial oxygen consumption using high-resolution respirometry. However, existing respirometry protocols are limited by the necessity for fresh tissue samples. This study developed a method with tailored substrate-inhibitor titration (TSIT) of mitochondrial electron transport complexes (ETC) to measure mitochondrial function in frozen cardiac samples using high-resolution respirometry. Briefly, acetyl-CoA was added to fuel the tricarboxylic acid (TCA) cycle for NADH production, enabling complex I (CI)-linked respiratory assessment. NADH was then added to measure maximum CI-linked respiratory capacity, followed by rotenone and succinate to assess complex II (CII)-linked respiratory capacity. TSIT detected mitochondrial functional differences between frozen atrial and ventricular tissue, with comparable results as measured in fresh samples. It also detected cardiac mitochondrial dysfunction across various (patho)physiological mouse models (including aging, ischemia reperfusion, obesity, and CI deficiency) as well as in frozen human donor samples, highlighting its clinical potential. Furthermore, we showed the first evidence for supercomplexes (SCs) formation between ETC-SCs and the TCA cycle metabolon, underpinning TSIT feasibility. In conclusion, we established a novel, robust, sensitive and translational method (TSIT) for assessing mitochondrial (dys)function in frozen cardiac samples from various species, enabling flexible analysis of mitochondrial function in both laboratory and clinical settings.

21 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RCRocco Caliandro
Rocco Caliandro
RBRuggero Belluomo
Ruggero Belluomo
JVJermo Hanemaaijer-Van der Veer
Jermo Hanemaaijer-Van der Veer
RORoelof-Jan Oostra
Roelof-Jan Oostra
Maurice J B van den HoffMaurice J B van den Hoff
Maurice J B van den Hoff
MGMonika Gladka
Monika Gladka
While single-cell RNA sequencing (scRNA-seq) has been the first widely adopted single-cell transcriptomic approach, its reliance on fresh tissue samples has substantially limited its applicability to clinically relevant specimen. Single-nucleus RNA sequencing (snRNA-seq) overcomes this constrain by enabling transcriptomic profiling from frozen material. However, isolating high-quality nuclei from frozen cardiac tissue remains technically challenging due to the dense extracellular matrix, complex tissue architecture, and heterogeneous cellular composition of the heart. To address these challenges, numerous nuclei isolation protocols have been adapted and optimized, resulting in substantial methodological heterogeneity across studies. Despite the widespread use of snRNA-seq in cardiac research, a robust and standardized nuclei isolation protocol that consistently yields high-quality nuclei from frozen human heart tissue is still lacking. Here, we present a comprehensive, end-to-end protocol for nuclei isolation from frozen human left ventricle, along with a detailed downstream pipeline for snRNA-seq data analysis. Our hybrid nuclei isolation strategy integrates multiple sequential clean-up steps designed to preserve nuclear integrity and RNA quality prior to sequencing. Compared with commonly used nuclei isolation protocols, this approach yields substantially higher number of nuclei while maintaining comparable numbers of detected genes and counts, even at lower sequencing depth. Adoption of this protocol may reduce technical variability across studies and facilitate more reproducible snRNA-seq analyses of human cardiac tissue.